BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0020
0.00 (0.00%)
May 26, 2026, 10:35 AM CET
BioSenic Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.5 | 0.39 | 0.12 | 1.85 | 0.76 |
Cash & Short-Term Investments | 0.5 | 0.39 | 0.12 | 1.85 | 0.76 |
Cash Growth | -38.60% | 234.19% | -93.66% | 143.22% | - |
Accounts Receivable | 2.96 | 0.31 | 0.29 | 1.21 | - |
Other Receivables | 0.23 | 0.71 | 1.16 | 1.2 | 0.36 |
Receivables | 3.18 | 1.01 | 1.46 | 2.41 | 0.36 |
Other Current Assets | 0.18 | 0.23 | 0.27 | 0.37 | 0 |
Total Current Assets | 3.86 | 1.63 | 1.85 | 4.63 | 1.12 |
Property, Plant & Equipment | 0 | 0.13 | 0.7 | 1.42 | 0.01 |
Long-Term Investments | - | 0.01 | 0.01 | 0.01 | - |
Goodwill | - | - | - | 1.8 | - |
Other Intangible Assets | - | 0 | 2.99 | 17.29 | - |
Long-Term Accounts Receivable | - | - | 0.4 | - | - |
Other Long-Term Assets | 0.63 | 2.96 | 3.62 | 4.17 | 0.03 |
Total Assets | 4.5 | 4.74 | 9.56 | 29.32 | 1.16 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.86 | 3.13 | 3.59 | 1.99 | 0.21 |
Accrued Expenses | 1.24 | - | 0.05 | 0.04 | - |
Short-Term Debt | - | - | - | 2.98 | - |
Current Portion of Long-Term Debt | 2.75 | 4.49 | 11.46 | 4.8 | 1.25 |
Current Portion of Leases | - | - | 0.36 | 0.23 | - |
Current Income Taxes Payable | - | 0 | 0.01 | - | - |
Current Unearned Revenue | - | - | 0.05 | 0.06 | - |
Other Current Liabilities | 0.47 | 0.33 | 0.33 | 0.25 | 0.03 |
Total Current Liabilities | 7.33 | 7.96 | 15.84 | 10.35 | 1.49 |
Long-Term Debt | 20.78 | 23.23 | 15.57 | 14.78 | 2.27 |
Long-Term Leases | - | - | 0.77 | 1 | - |
Pension & Post-Retirement Benefits | - | 0.08 | 0.08 | 0.07 | - |
Other Long-Term Liabilities | - | 0.28 | - | 0 | 0.07 |
Total Liabilities | 28.1 | 31.55 | 32.26 | 26.2 | 3.83 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 38.4 | 8.58 | 6.28 | 4.77 | 0.66 |
Additional Paid-In Capital | 15.8 | 6.02 | 5.72 | 4.52 | 3.97 |
Retained Earnings | -77.8 | -39.59 | -34.89 | -5.72 | -7.22 |
Comprehensive Income & Other | - | -0.07 | -0.02 | -0.04 | -0.08 |
Total Common Equity | -23.6 | -25.07 | -22.91 | 3.53 | -2.67 |
Minority Interest | - | -1.74 | 0.21 | -0.4 | - |
Shareholders' Equity | -23.6 | -26.81 | -22.71 | 3.12 | -2.67 |
Total Liabilities & Equity | 4.5 | 4.74 | 9.56 | 29.32 | 1.16 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 23.53 | 27.73 | 28.16 | 23.79 | 3.53 |
Net Cash (Debt) | -23.03 | -27.34 | -28.04 | -21.94 | -2.77 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.05 | -0.12 | -0.20 | -0.18 | -41.86 |
Filing Date Shares Outstanding | 652.86 | 323.93 | 163.18 | 240.19 | 0.07 |
Total Common Shares Outstanding | 652.86 | 323.93 | 163.18 | 240.19 | 0.07 |
Working Capital | -3.46 | -6.32 | -14 | -5.73 | -0.37 |
Book Value Per Share | -0.04 | -0.08 | -0.14 | 0.01 | -40.40 |
Tangible Book Value | -23.6 | -25.08 | -25.9 | -15.57 | -2.67 |
Tangible Book Value Per Share | -0.04 | -0.08 | -0.16 | -0.06 | -40.40 |
Buildings | - | 0.14 | 0.92 | - | - |
Machinery | - | 0.08 | 0.15 | 0.07 | - |
Construction In Progress | - | - | - | 0.14 | - |